These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27899316)

  • 1. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
    Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
    Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of astrocytic transglutaminase 2 improves injury outcomes.
    Monteagudo A; Feola J; Natola H; Ji C; Pröschel C; Johnson GVW
    Mol Cell Neurosci; 2018 Oct; 92():128-136. PubMed ID: 29969654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
    van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
    PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
    Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
    Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
    Colak G; Johnson GV
    Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
    Quinn BR; Yunes-Medina L; Johnson GVW
    J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
    Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
    J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.
    Espitia Pinzón N; Brevé JJP; Bol JGJM; Drukarch B; Baron W; van Dam AM
    J Neuroinflammation; 2017 Dec; 14(1):260. PubMed ID: 29282083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
    Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
    Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
    van Strien ME; Drukarch B; Bol JG; van der Valk P; van Horssen J; Gerritsen WH; Breve JJ; van Dam AM
    Brain Pathol; 2011 Jan; 21(1):44-54. PubMed ID: 20731658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
    PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TG2 in regulating S100A4-mediated mammary tumour cell migration.
    Wang Z; Griffin M
    PLoS One; 2013; 8(3):e57017. PubMed ID: 23469180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
    Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
    FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
    Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
    Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
    Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory Matrix.
    Emerson J; Delgado T; Girardi P; Johnson GVW
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells.
    Caron NS; Munsie LN; Keillor JW; Truant R
    PLoS One; 2012; 7(8):e44159. PubMed ID: 22952912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.
    Rudlong J; Cheng A; Johnson GVW
    Anal Biochem; 2020 Feb; 591():113556. PubMed ID: 31866289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
    Agnihotri N; Mehta K
    Amino Acids; 2017 Mar; 49(3):425-439. PubMed ID: 27562794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.